📢 Brazil and Thailand become the first malaria-endemic countries to launch new single-dose relapse prevention medicine for Plasmodium vivax (P. vivax) malaria P. vivax is the dominant malaria parasite in many countries outside of sub-Saharan Africa and is characterised by clinical relapses. Without treatment for the latent liver-stage infection, patients experience repeated bouts of illness, imposing significant physical, economic, and social burdens on both individuals and communities. Relapses also increase the disease burden and the potential for onward transmission, ultimately impeding global efforts to eliminate malaria. Developed through a longstanding partnership Medicines for Malaria Venture, tafenoquine, co-administered with chloroquine, offers a new potential treatment option for vulnerable populations who are disproportionately affected by this disease. By continuing to invest in global health R&D, strengthening healthcare systems, and enabling access to healthcare in lower-income countries, together with our partners we can help change the trajectory of malaria. #ChangeTheTrajectory #Malaria #GlobalHealth #ZeroMalaria
Exciting news! Brazil and Thailand lead the way in fighting Plasmodium vivax malaria with a new single-dose relapse prevention medicine. This innovation promises to alleviate significant burdens on affected communities and advance global malaria elimination efforts. #ChangeTheTrajectory #Malaria #GlobalHealth #ZeroMalaria
Kudos, GSK! This achievement underscores the importance of global health R&D and collaboration in our collective efforts to eliminate malaria and improve health outcomes worldwide.
This is a complete gamechanger! As someone who grew up in the tropics, the fear and potential negative consequences of catching malaria are immense and haunt you day in and out throughout the entire year. No better way to mitigate the harmful impacts of an infectious disease than through a prophylaxis one, such as a vaccine!
Hello sir, I have opened medical wholesale business in Katihar, Bihar. I have tried getting medical representative for our area but couldn't get any data, it seems there is not a single Medical Representative for GSK operating in this district, which have population more than 5 millions. Please look into this and give some insight. My contact - 8860362149
Great news. This is a very promising development in the fight against malaria.🤗
Amazing!! This will help so many communities to live better!
Malaria has been around for over 4 decades…. It’s about time that it becomes another history!! 🙏🏾🙏🏾🙏🏾🙏🏾
Wonderful to be able to see malaria being stopped and spread.
Retired disease and product marketing specialist at GlaxoSmithKline
1moCongratulations to the many people at GSK and MMV for finally getting this medicine out there to patients. It has taken a long time and a lot of effort to get to this stage. It will be interesting to see the impact it makes in Brazil and Thailand and hopefully that will lead to more widespread use and support global elimination efforts.